Supplement: Changes in expression under MET-stress in CAPAN1 and CFPAC1. Significant (<0.05) changes of 2.5 fold or greater that occur in cultures under MET-stress for either CAPAN1 or CFPAC for 4 and 6 d respectively, are listed. NE: not expressed denotes relative expression of less than 200 in both methionine (M) and homocysteine (H) sets. CAPAN1 CAPAN1 CFPAC1 CFPAC1 GENE SYMBOL MET HCYS M/H MET HCYS M/H Growth arrest and DNA-damage-inducible, beta GADD45B chr19p13.3 47.4 2605.4 0.02 546.5 978.9 0.56 clusterin CLU chr8p21-p12 31 610.2 0.05 NE cyclin-dependent kinase 5 CDK5 chr7q36 44 502.3 0.09 286.1 628.4 0.46 SMAD, mothers against DPP homolog 7 SMAD7 chr18q21.1 30.1 337.2 0.09 410.8 968.3 0.63 colony stimulating factor 1 (macrophage) CSF1 chr1p21-p13 50.4 487.1 0.10 1105.5 1741.8 0.42 breast cancer 1, early onset BRCA1 chr17q21 31.6 316.5 0.11 125.5 427.1 0.29 TGF, beta receptor associated 1 TGFBRAP1 chr2q12.1 72.9 648.9 0.11 NE tuftelin interacting protein 11 TFIP11 chr22q12.1 63.8 561.5 0.11 212.2 382 0.56 three prime repair 1 TREX1 chr3p21.3-p21.2 39.8 310.1 0.13 59.5 310.8 0.19 v-ets erythroblastosis virus E26 oncogene homolog2 ETS2 chr21q22.3|21q22.2 105 807.1 0.13 615.9 414.2 1.49 growth differentiation factor 15 GDF15 chr19p13.1-13.2 275 1940.1 0.14 4961.8 6636.5 0.75 c-myc binding protein MYCBP chr1p33-p32.2 32.4 226.8 0.14 448.6 525.5 0.85 protein (peptidyl-prolyl cis/trans ) 1 PIN1 chr19p13 102 683.8 0.15 NE putative lymphocyte G0/G1 switch gene G0S2 chr1q32.2-q41 1485.3 9136.8 0.16 613.6 2458.5 0.25 -like growth factor binding protein 4 IGFBP4 chr17q12-q21.1 185.7 1113.8 0.17 914.2 2643.7 0.35 sphingosine kinase 2 SPHK2 chr19q13.2 139.3 832.8 0.17 62 360.5 0.17 neurofibromin 2 NF2 chr22q12.2 131.7 561.4 0.23 364.6 687.5 0.53 S100 calcium binding protein A3 S100A3 chr1q21 282.3 1167.7 0.24 28.3 389.4 0.07 immediate early response 3 IER3 chr6p21.3 2648.1 10433.2 0.25 17681.9 24362.4 0.73 interferon, gamma-inducible protein 16 IFI16 chr1q22 75.6 271.7 0.28 2023.9 2653 0.76 RAD51 homolog C RAD51C chr17q22-q23 150.7 538.6 0.28 370.3 710.3 0.52 guanine nucleotide binding protein (), GNA11 chr19p13.3 75 265.1 0.28 553.9 639.5 0.87 methionine adenosyltransferase II, alpha MAT2A chr2p11.2 3776.7 12193.4 0.31 1368.7 3525.9 0.39 cyclin-dependent kinase inhibitor 2C (p18) CDKN2C chr1p32 278.4 896.5 0.31 148.2 288.2 0.51 mesenchymal stem cell protein DSC92 NEUGRIN chr15q26.1 1297.6 4097.2 0.32 3687.8 5289.8 0.70 BCL2-associated athanogene 5 BAG5 chr14q32.32 1093.7 3264.9 0.34 1288.2 2283.4 0.56 thioredoxin TXN chr9q31 3013.3 8415 0.36 3363.2 3120.3 1.08 BCL2-associated athanogene 3 BAG3 chr10q25.2-q26.2 619.8 1660.3 0.37 857.3 1565.7 0.55 BH3 interacting domain death agonist BID chr22q11.1 1192.2 2777.6 0.43 640.1 1499.7 0.43 Interferon-related developmental regulator 1 IFRD1 chr7q22-q31 700.9 1189.4 0.43 272.4 391.1 0.70 IFN-induced protein with tetratricopeptide repeats 2 IFIT2 chr10q23-q25 326.8 708.8 0.46 255.4 1164.5 0.22 superoxide dismutase 2, mitochondrial SOD2 chr6q25.3 388.7 756.8 0.51 361.8 1400.3 0.26 cyclin D1 CCND1 chr11q13 792 1404.2 0.56 1037 1319.3 0.79 interferon gamma receptor 1 IFNGR1 chr6q23-q24 981.4 1709.7 0.57 1202.5 3844.9 0.31 interferon regulatory factor 1 IRF1 chr5q31.1 852.1 1284.2 0.66 1203.4 2996.9 0.40 interleukin 8 IL8 chr4q13-q21 1617.3 2385.2 0.68 4411.3 12319.5 0.36 intercellular adhesion molecule 1 (CD54), ICAM1 chr19p13.3-p13.2 480.7 674.7 0.71 412.1 1477.3 0.28 TGFB inducible early growth response TIEG chr8q22.2 1195.6 1670.1 0.72 2002.6 4534.4 0.44 pentaxin-related gene, rapidly induced by IL-1 beta PTX3 chr3q25 2866.7 3983.7 0.72 138.8 523.2 0.27 BCL2-antagonist of cell death BAD chr11q13.1 646.4 889.9 0.73 594.7 963.9 0.62 BCL2-antagonist/killer 1 BAK1 chr6p21.3 525.2 708.7 0.74 640.9 857.1 0.75 2'-5'-oligoadenylate synthetase 3, 100kDa OAS3 chr12q24.2 486.6 587.5 0.82 730.5 1087 0.67 colony stimulating factor 3 (granulocyte) CSF3 chr17q11.2-q12 705.7 857.9 0.82 64.5 324.7 0.20 Rho guanine nucleotide exchange factor (GEF) 12 ARHGEF12 chr11q23.3 747.9 901.6 0.83 NE BRCA1 associated protein-1 BAP1 chr3p21.31-p21.2 817.5 952.8 0.86 276.7 1112 0.25 pim-2 oncogene PIM2 chrXp11.23 522.2 504 1.04 347.6 1239.8 0.28 cell division cycle 25B CDC25B chr20p13 1442.2 1110.4 1.30 1201.3 3222.9 0.37 epidermal growth factor receptor EGFR chr7p12 928.5 694.4 1.34 430 89.4 4.81 H1 RNASEH1 chr2p25 1011 697.6 1.45 539.4 173.4 3.11 insulin induced gene 1 INSIG1 chr7q36 519.4 310.6 1.67 1351.6 42.1 32.11 early growth response 3 EGR3 chr8p23-p21 679.9 375.6 1.81 NE WEE1 homolog (S. pombe) WEE1 chr11p15.3-p15.1 463.7 201.2 2.30 709.4 606.6 1.17 cyclin A2 CCNA2 chr4q25-q31 219.6 78.5 2.80 239.1 187.8 1.27 serum/glucocorticoid regulated kinase SGK chr6q23 13360 4694.5 2.85 1025.6 4,409.4 0.23 glutaminyl-tRNA synthetase QARS chr3p21.3-p21.1 2069.9 688.5 3.01 2341.6 1604.1 1.46 early growth response 1 EGR1 chr5q31.1 1305.6 424.9 3.07 2177.1 1297.5 1.68 excision repair cross-complement repair deficiency ERCC1 chr19q13.2-q13.3 3856.8 1250.7 3.08 514.9 569.4 0.90 BUB1 budding uninhibited by benzimidazoles 1 BUB1 chr2q14 727.9 234 3.11 320 140.6 2.28 CDC42 effector protein (Rho GTPase binding) 3 CDC42EP3 chr2p21 1941.5 621.2 3.13 777.8 539 1.44 cyclin G1 CCNG1 chr5q32-q34 6177.9 1942.6 3.18 2823.1 1893.4 1.49 glucose regulated protein, 58kDa GRP58 chr15q15 1947.6 602.3 3.23 4143.4 1049.2 3.95 nuclear receptor subfamily 4, group A, member 1 NR4A1 chr12q13 469.1 143.4 3.27 394.1 110.1 3.58 mutS homolog 6 MSH6 chr2p16 834.9 251.5 3.32 533.9 480.8 1.11 cyclin B1 CCNB1 chr5q12 1510.3 453.4 3.33 791.5 336.9 2.35 nucleosome assembly protein 1-like 1 NAP1L1 chr12q21.2 11201.2 3338.5 3.36 5557 3470.8 1.60 C, beta 3 (phosphatidylinositol- spec.) PLCB3 chr11q13 504.3 150 3.36 316 176.4 1.79 MAD2 mitotic arrest deficient-like 1 (yeast) MAD2L1 chr4q27 523.7 155.2 3.37 514.5 455 1.13 Cell division cycle 2, G1 to S and G2 to M CDC2 chr10q21.1 417 121 3.45 616.1 196.1 3.14 v-jun sarcoma virus 17 oncogene homolog (avian) JUN chr1p32-p31 704.8 203 3.47 4826 2801.6 1.72 I-like 1 DNASE1L1 chrXq28 835.8 237.9 3.51 814 615.7 1.32 poly(A) binding protein, cytoplasmic 4 (inducible) PABPC4 chr1p32-p36 5326.5 1449.6 3.67 3096.1 1613.6 1.92 androgen-induced proliferation inhibitor APRIN chr13q12.3 476.8 128.3 3.72 209.7 72.6 2.89 Ras homolog gene family, member B RHOB chr2p24 2306.3 618.9 3.73 5804.2 4537.3 1.28 stanniocalcin 1 STC1 chr8p21-p11.2 1945.9 511.9 3.80 NE ubiquitin-conjugating E2C UBE2C chr20q13.12 2190.1 569.5 3.85 1393.4 512.2 2.72 septin 10 10-Sep chr2q13 2733.6 694.7 3.93 NE aurora kinase B AURKB chr17p13.1 824.7 209.1 3.94 296.5 178 1.67 transducin (beta)-like 3 TBL3 chr16p13.3 468.3 115.6 4.05 505.6 572.4 0.88 antigen identified by monoclonal antibody Ki-67 MKI67 chr10q25-qter 143.7 33.6 4.28 308.7 51 6.05 polo-like kinase 1 (Drosophila) PLK1 chr16p12.1 147.8 34.3 4.31 309.9 79.7 3.89 amphiregulin (schwannoma-derived growth factor) AREG chr4q13-q21 2295.2 518.4 4.43 2725.8 822.8 3.31 integrin, beta 4 ITGB4 chr17q25 1707.4 378.2 4.51 3414.5 1444.7 2.36 interferon induced transmembrane protein 1 (9-27) IFITM1 chr11p15.5 1805.8 378.2 4.77 4312.3 5114.2 0.84 Fanconi anemia, complementation group L FANCL chr2p16.1 459.7 95.8 4.80 263.3 230.4 1.14 insulin receptor substrate 2 IRS2 chr13q34 1000 207.1 4.83 2426 1650.5 1.47 protein regulator of cytokinesis 1 PRC1 chr15q26.1 615.6 118.7 5.19 762 252.1 3.023 Cell division cycle 2-like 6 (CDK8-like) CDC2L6 chr6q21 578.7 110.8 5.22 284 255.7 1.11 casein kinase 1, epsilon CSNK1E chr22q13.1 473.3 88.8 5.33 201.3 20.1 10.01 epiregulin EREG chr4q13.3 4513.6 819.3 5.51 2992.5 2074.2 1.44 thymidylate synthetase TYMS chr18p11.32 2251.8 404.7 5.56 360.2 231.7 1.55 serine (or cysteine) proteinase inhibitor, clade A SERPINA3 chr14q32.1 1231.1 216.4 5.69 402.7 1177 0.34 O-6-methylguanine-DNA methyltransferase MGMT chr10q26 336.2 57.8 5.82 404.8 43.3 9.34 high-mobility group box 2 HMGB2 chr4q31 2304.1 353.9 6.51 1129.5 571.2 1.98 tumor protein p73-like TP73L chr3q27-q29 494.9 71.6 6.91 NE nucleolar and spindle associated protein 1 NUSAP1 chr15q15.1 726.2 104.9 6.92 523.5 303 1.73 dual specificity 6 DUSP6 chr12q22-q23 525.1 74.2 7.08 2728.5 1441.9 1.89 protein tyrosine phosphatase-like PTPLA chr10p14-p13 722.6 97.1 7.44 505.5 415.3 1.22 dual specificity phosphatase 1 DUSP1 chr5q34 10036.3 1310.4 7.66 21249.1 15608.9 1.36 DNA replication factor CDT1 chr16q24.3 472.1 58.2 8.11 374.7 267.6 1.40 Fanconi anemia, complementation group A FANCA chr16q24.3 617.8 67.8 9.11 254.4 76.4 3.33 Cell division cycle associated 8 CDCA8 chr1p34.3 513.5 55.1 9.32 342.8 61.3 5.59 growth arrest-specific 1 GAS1 chr9q21.3-q22 492.4 47.4 10.39 NE dual specificity phosphatase 2 DUSP2 chr2q11 465.4 44.7 10.41 NE topoisomerase (DNA) II alpha 170kDa TOP2A chr17q21-q22 1280.4 92.3 13.87 1457 748.1 1.95 Kruppel-like factor 6 KLF6 chr10p15 1080.8 51.6 20.95 1037.7 342.7 3.03 kinetochore associated 2 KNTC2 chr18p11.32 809.5 36.4 22.24 NE kinesin family member 20A KIF20A chr5q31 639.7 28.1 22.77 584.5 104.6 5.59 lectin, galactoside-binding, soluble, 1 (galectin 1) LGALS1 chr22q13.1 9930.3 272.8 36.40 602.1 638.4 0.94 cyclin B2 CCNB2 chr15q22.2 1235.3 30.1 41.04 759.6 304.8 2.49 FBJ osteosarcoma viral oncogene homolog B FOSB chr19q13.32 2067.1 41.1 50.29 5175.6 3983 1.30 NIMA (never in mitosis gene a)-related kinase 2 NEK2 chr1q32.2-q41 415.1 5.4 76.87 251.2 26.4 9.52 v-fos FBJ osteosarcoma viral oncogene homolog FOS chr14q24.3 8484.9 100.6 84.34 19019.7 13098.7 1.45 S100 calcium binding protein A8 (calgranulin A) S100A8 chr1q21 NE 129.7 2304.4 0.06 protease inhibitor 3, skin-derived (SKALP) PI3 chr20q12-q13 NE 640.9 9162.8 0.07 colony stimulating factr 2 (granulocyte- macrophage) CSF2 chr5q31.1 NE 53.5 727.1 0.07 suppressor of cytokine signaling 1 SOCS1 chr16p13.13 NE 37.3 422.4 0.09 Serine/cysteine proteinase inhibitor, clade B SERPINB4 chr18q21.3 NE 82.9 834.5 0.10 serine (or cysteine) proteinase inhibitor, clade A SERPINA5 chr14q32.1 NE 161.8 888.2 0.18 chemokine ligand 6 (granulocyte chemotactic 2) CXCL6 chr4q21 NE 1004.4 4880.3 0.21 heat shock 70kDa protein 5 HSPA5BP1 chr11q12.2 NE 215.2 984.9 0.22 tenascin C (hexabrachion) TNC chr9q33 NE 134.5 570.4 0.24 fibrinogen, B beta polypeptide FGB chr4q28 NE 473.5 1961.7 0.24 serine (or cysteine) proteinase inhibitor, clade B SERPINB3 chr18q21.3 NE 638.1 2423.9 0.26 guanylate binding protein 1, IFN-inducible, 67kDa GBP1 chr1p22.2 NE 478.3 1790.2 0.27 prostaglandin-endoperoxide synthase 2 PTGS2 chr1q25.2-q25.3 NE 1772.6 6544 0.27 S100 calcium binding protein A9 (calgranulin B) S100A9 chr1q21 NE 1070 3905.8 0.27 serine protease inhibitor, Kazal type 1 SPINK1 chr5q32 NE 1293.5 4623.8 0.28 chondroitin sulfate proteoglycan 2 (versican) CSPG2 chr5q14.3 NE 154.2 505.7 0.31 phosphoinositide-3-kinase, PIK3C2B chr1q32 NE 314.6 1000.3 0.32 interleukin 6 (interferon, beta 2) IL6 chr7p21 NE 1819.7 3530.2 0.52 interferon regulatory factor 7 IRF7 chr11p15.5 NE 573.1 1055.2 0.54 BCL2-interacting killer (apoptosis-inducing) BIK chr22q13.31 NE 1607.1 1826.5 0.88 transforming growth factor, alpha TGFA chr2p13 NE 2113.3 1150.5 1.84 interferon regulatory factor 2 IRF2 chr4q34.1-q35.1 NE 605.2 300 2.01 inositol polyphosphate-4-phosphatase, type II 105kD INPP4B chr4q31.21 NE 458.2 148.7 3.08 TGF (ligand) superfamily, member 11 TNFSF11 chr13q14 NE 321.9 96.9 3.32 interleukin 18 (interferon-gamma-inducing factor) IL18 chr11q22.2-q22.3 NE 337.9 96 3.52 angiotensin II receptor, type 1 AGTR1 chr3q21-q25 NE 2314.6 583 3.97 coagulation factor II (thrombin) receptor F2R chr5q13 NE 1176.6 197.2 5.97 interferon stimulated gene 20kDa ISG20 chr15q26 NE 664.5 84.8 7.84 macrophage stimulating 1 receptor MST1R chr3p21.3 NE 637.2 71.7 8.89 lymphocyte-specific protein LCK chr1p34.3 NE 433.4 33.9 12.79 myelin transcription factor 1 MYT1 chr20q13.33 NE NE